lilotomab   

GtoPdb Ligand ID: 9950

Synonyms: Betalutin® | HH1 | tetulomab
Compound class: Antibody
Comment: Lilotomab is an investigational murine anti-CD37 monoclonal antibody [1]. A radioimmunoconjugate version that can be loaded with the beta radiation-emitting isotope lutetium-177 (known as 177Lu-lilotomab satetraxetan, and as the trade name Betalutin) is being evaluated as a novel radioimmunotherapeutic for the treatment of non-Hodgkin lymphoma [2]. Satetraxetan is the name of the radionuclide chelator, and this is a DOTA derivative known as (p-SCN-Bn)-DOTA (PubChem CID 10123265).
No information available.
Summary of Clinical Use
Click here to link to a complete list of lilotomab clinical studies that are registered at ClinicalTrials.gov.